| Localized irradiation of cell membrane by Auger electrons is cytotoxic through oxidative stress-mediated nontargeted effects S Paillas, R Ladjohounlou, C Lozza, A Pichard, V Boudousq, M Jarlier, ... Antioxidants & redox signaling 25 (8), 467-484, 2016 | 86 | 2016 |
| Immunotherapy of triple-negative breast cancer with cathepsin D-targeting antibodies Y Ashraf, H Mansouri, V Laurent-Matha, LB Alcaraz, P Roger, S Guiu, ... Journal for Immunotherapy of Cancer 7, 1-17, 2019 | 77 | 2019 |
| Targeted cancer therapy with a novel anti-CD37 beta-particle emitting radioimmunoconjugate for treatment of non-Hodgkin lymphoma AHV Repetto-Llamazares, RH Larsen, S Patzke, KG Fleten, ... PLoS One 10 (6), e0128816, 2015 | 37 | 2015 |
| Tetraspanin 8 (TSPAN 8) as a potential target for radio-immunotherapy of colorectal cancer A Maisonial-Besset, T Witkowski, I Navarro-Teulon, O Berthier-Vergnes, ... Oncotarget 8 (13), 22034, 2017 | 36 | 2017 |
| Drugs that modify cholesterol metabolism alter the p38/JNK-mediated targeted and nontargeted response to alpha and auger radioimmunotherapy R Ladjohounlou, C Lozza, A Pichard, J Constanzo, J Karam, P Le Fur, ... Clinical Cancer Research 25 (15), 4775-4790, 2019 | 33 | 2019 |
| Realistic multi-cellular dosimetry for 177Lu-labelled antibodies: model and application S Marcatili, A Pichard, A Courteau, R Ladjohounlou, I Navarro-Teulon, ... Physics in Medicine & Biology 61 (19), 6935, 2016 | 28 | 2016 |
| The anti-tumor efficacy of 3C23K, a glyco-engineered humanized anti-MISRII antibody, in an ovarian cancer model is mainly mediated by engagement of immune effector cells P Estupina, A Fontayne, JM Barret, N Kersual, O Dubreuil, M Le Blay, ... Oncotarget 8 (23), 37061, 2017 | 25 | 2017 |
| Radiolabeled antibodies against müllerian-inhibiting substance receptor, type II: new tools for a theranostic approach in ovarian cancer E Deshayes, R Ladjohounlou, P Le Fur, A Pichard, C Lozza, V Boudousq, ... Journal of Nuclear Medicine 59 (8), 1234-1242, 2018 | 21 | 2018 |
| The antitumor efficacy of 3C23K, a glyco-engineered humanized anti-MISRII antibody, in an ovarian cancer model is mainly mediated by engagement of immune effector cells … P Estupina, A Fontayne, JM Barret, N Kersual, O Dubreuil, M Le Blay, ... | 3 | |
| Dose-effect relationship during alpha-RIT of small volume peritoneal carcinomatosis using Pb-212-labeled mAbs J Pouget, R Ladjohounlou, A Pichard, V Boudousq, L Bobyk, S Paillas, ... European Journal of Nuclear Medicine and Molecular Imaging 41, S191-S192, 2014 | 2 | 2014 |
| Anti-MISRII radiolabeled antibodies: new tools for a theranostic approach in ovarian cancer E Deshayes, R Ladjohounlou, P Le Fur, A Pichard, C Lozza, V Boudousq, ... Journal of Nuclear Medicine, 2018 | 1 | 2018 |
| Localized irradiation of cell membrane by Auger electrons is cytotoxic through non-targeted effects involving p38 and JNK signaling pathways S Paillas, R Ladjohounlou, C Lozza, A Pichard, V Boudousq, M Jarlier, ... EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 43, S163-S164, 2016 | 1 | 2016 |
| Therapeutic efficacy of brief intraperitoneal radioimmunotherapy of ovarian cancer using 213Bi-anti MISRII antibodies R LADJOHOUNLOU, A Pichard, E DEHAYES, V Boudousq, ... | 1 | 2016 |
| Involvement of direct and indirect (bystander) cytotoxic effects in alpha-RIT of small volume peritoneal carcinomatosis using Pb-212-labeled mAbs J Pouget, R Ladjohounlou, A Pichard, V Boudousq, S Paillas, M Le Blay, ... EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 42, S201-S202, 2015 | 1 | 2015 |
| Theranostic approach in ovarian cancer using Anti-MISRII radiolabeled antibodies JP POUGET, E DESHAYES, R LADJOHOUNLOU, FUR LE, A PICHARD, ... | | 2018 |
| Study of a new anti-CD37 monoclonal antibody radiolabelled with Luthetium-177 in a B-cell Non-Hodgkin Lymphoma: therapeutic efficacy and mechanisms of action A Pichard Université Montpellier, 2017 | | 2017 |
| Etude d'un nouvel anticorps anti-CD37 radiomarqué au Lutétium-177 dans le traitement du lymphome B non hodgkinien: efficacité thérapeutique et mécanismes d'action A Pichard Montpellier, 2017 | | 2017 |
| Involvement of cell cycle checkpoints in the therapeutic efficacy of Lu-177-lilotomab in non-Hodgkin B-cell lymphoma A Pichard, A Courteau, S Marcatili, G Cartron, II Navarro-Teulon, ... EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 44, S138-S139, 2017 | | 2017 |
| Targeted radionuclide therapy of non-Hodgkin B-cell lymphoma using Lu-177-lilotomab or Lu-177-rituximab: a radiobiological approach A Pichard, S Marcatili, A Courteau, R Ladjohounlou, G Cartron, ... EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 43, S155-S156, 2016 | | 2016 |
| Contribution of direct and bystander effects to therapeutic efficacy of alpha-RIT using 212Pb-labeled mAbs R Ladjohounlou, A Pichard, V Boudousq, S Paillas, M Le Blay, C Lozza, ... Radiotherapy and Oncology 1 (118), S85-S86, 2016 | | 2016 |
